Florien Boele,Se Frances,Amelie Darlix,Francois Ducray,Emeline Tabouret,Michael Burger,Isabelle Ryden,Annika Malmstrom,Elodie Vauleon,Tomas Kazda,Mirjam Renovanz,Jan-Michael Werner,Liam Welsh,Paul Sanghera,Caroline Dehais,Isacco Desideri,Catherine McBain,Shaveta Mehta,Hannah Lord,Rajesh Jena,Karen Foweraker,Keyoumars Ashkan,Julien Engelhardt,Veronique Bourg,Ulrich Herrlinger,Aaron Lawson McLean,Caroline Hertler,Lene Haldbo-Classen,Rikke Dahlrot,Georges Noel,Xavier Durando,Ioana Hrab,Evangelia Razis,Aida Muhic,Martin Klein

Abstract:Patients with oligodendroglioma have a relatively favourable prognosis. Treatment modalities used vary, and the long-term impacts of the tumour itself and its treatment on health-related quality of life (HRQOL) and cognition remain largely unclear. We investigated associations between treatment and functioning of oligodendroglioma patients. In this international cross-sectional observational study, patients with oligodendroglioma (IDH-mutant and 1p/19q-codeleted) diagnosed ≥5 years ago, were recruited through the European Organisation for Research and Treatment of Cancer (EORTC) networks. Diagnosis and treatment data were collected from medical records; patients completed outcomes for HRQOL (EORTC QLQ-C30; BN20), self-reported cognitive functioning (MOS Cognitive Complaints Scale) and cognitive tests (HVLT-R, TMT, COWAT). Associations between HRQOL and cognition outcomes, and clinical variables (time since diagnosis; progression; tumour location; treatments delivered; current medication; Karnofsky Performance Status (KPS)) were explored with regression analyses. 242 oligodendroglioma patients on average 9.9 years post-diagnosis (sd=4.3, range=5.0-26.3) took part from 33 sites across 9 countries. Patients were M =52 years old (sd=12, range=23-78), the majority were men ( N =145; 60%). Higher KPS, no radiotherapy (ever), no current medication (anxiolytics/sedatives; antidepressants; dexamethasone) were associated with better generic HRQOL outcomes (QLQ-C30 functioning scale models; R 2 range 0.068-0.371, all p<.001). Higher KPS, fewer recurrences, no radiotherapy treatment (ever), and no current antidepressant use were linked to better disease-specific HRQOL (BN20 multi-item scale models; R 2 range 0.067-0.246, p<0.001). Fewer subjective cognitive complaints were associated with higher KPS and no current antipsychotic medication (R 2 =0.153, p<0.001). Better KPS, right hemispheric tumours, longer time since diagnosis, no chemotherapy (ever), no radiotherapy (ever), and no current medications (dexamethasone; antipsychotics) were predictive of better cognitive functioning (R 2 range 0.056-0.248, p<0.001). In oligodendroglioma survivors, better HRQOL and cognitive outcomes appeared consistently linked with higher KPS, no current medication use, and never having received radiotherapy. Additionally, better cognitive outcomes were associated with no chemotherapy treatment.

QOL-31. NEUROPSYCHOLOGICAL FUNCTIONING AND QUALITY OF LIFE IN INFANT AT/RT SURVIVORS: FOCUS ON FLUID INTELLIGENCE AND VISUAL PROCESSING

Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies

QOL-35. ANALYSIS ON THE EVOLUTIONARY PATTERN OF COGNITIVE FUNCTIONS IN CHILDREN ON FOLLOW-UP FOR BRAIN TUMORS

Neurocognitive function and health-related quality of life in a nationwide cohort of long-term childhood brain tumor survivors

QOL-48. NEUROPSYCHOLOGICAL INTERVENTION FOR PEDIATRIC BRAIN TUMOR PATIENTS AND SURVIVORS - A PRE-STUDY WITH A FOCUS ON PATIENT INVOLVEMENT

Trajectories of psychosocial and cognitive functioning in pediatric patients with brain tumors treated with radiation therapy

Qol-14. Health-Related Quality Of Life And Cognitive Functioning In Survivors Of Oligodendroglioma: An International Cross-Sectional Investigation

Late neurocognitive sequelae in survivors of brain tumours in childhood

Quality of life and late‐effects among childhood brain tumor survivors: a mixed method analysis

Strategies to improve the quality of survival for childhood brain tumour survivors

QOL-10. NOVEL MULTIMODAL STUDY OF THREE COGNITIVE REHABILITATION INTERVENTIONS IN LOWER GRADE GLIOMA

Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study

Long term quality of life outcomes following surgical resection alone for benign paediatric intracranial tumours

Psychosocial and executive functioning late effects in pediatric brain tumor survivors after proton radiation

Neuropsychological outcomes of patients with low-grade glioma diagnosed during the first year of life

Primary Atypical Teratoid/Rhabdoid Tumor Of Central Nervous System In Children: A Clinicopathological Analysis And Review Of Literature In China

Long term neuropsychological outcomes of a pediatric ETANTR brain tumor: A case study

Retrospective study of late radiation-induced damages after focal radiotherapy for childhood brain tumors

Neuropsychological rehabilitation for survivors of childhood and adolescent brain tumors: a view of the past and a vision for a promising future

Neuropsychological Late Effects and Quality-of-Life Outcomes in Pediatric Brain Tumor Survivors: Role of Pediatric Neurologists in Monitoring and Management

Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors